drugset / Trial / NCT04389359
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion
Phase 2/3
Withdrawn
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The PROTECT open-label randomised basket trial will assess the effectiveness of hydroxychloroquine (HCQ) as chemoprophylaxis against COVID-19 in multiple vulnerable populations in the United Kingdom.
Timeline
- Start
- 2020-09
- Primary completion
- 2021-08
- Completion
- 2025-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 200 mg | Oral |
| Subject | Hydroxychloroquine | Small molecule | 400 mg | Oral |